Skip to main content
. 2020 Dec 30;3(2):e24827. doi: 10.2196/24827

Table 2.

Perceptions related to COVID-19 vaccination.

Acceptability and perceptions Value (N=1052),
n (%) or mean (SD)
Parents’ acceptability of COVID-19 vaccination for their child under the age of 18 years: likelihood of having the child take up free COVID-19 vaccination, n (%)

Very unlikely 19 (1.8)

Unlikely 45 (4.3)

Neutral 224 (21.3)

Likely 361 (34.3)

Very likely 403 (38.3)
Perceptions related to COVID-19 vaccination based on the theory of planned behavior

Positive attitudes toward COVID-19 vaccination


Positive Attitude Scalea score, mean (SD) 8.0 (1.2)


COVID-19 vaccination is highly effective in protecting your child from COVID-19 (agree), n (%) 603 (57.3)


Taking up COVID-19 vaccination can contribute to the control of COVID-19 in China (agree), n (%) 896 (85.2)


China will have an adequate supply of COVID-19 vaccine (agree), n (%) 763 (72.5)

Negative attitudes toward COVID-19 vaccination


Negative Attitude Scaleb score, mean (SD) 7.7 (1.6)


Your child will have severe side effects after receiving COVID-19 vaccination (agree), n (%) 104 (9.9)


The protection of COVID-19 vaccines will only last for a short time (agree), n (%) 210 (20.0)


Your child is afraid of vaccination (agree), n (%) 216 (20.5)


You do not have time to take your child for COVID-19 vaccination (agree), n (%) 234 (22.2)

Perceived subjective norm related to child’s COVID-19 vaccination: your family member would support you in having your child take up COVID-19 vaccination


Response score, mean (SD)c 2.5 (0.6)


Agree, n (%) 542 (51.5)

Perceived behavioral control to have the child take up COVID-19 vaccination: having the child receive COVID-19 vaccination is easy for you if you want them to


Response score, mean (SD)c 2.3 (0.7)


Agree, n (%) 456 (43.3)
Influence of social media related to COVID-19 vaccination

Frequency of exposure to positive information related to COVID-19 vaccination (eg, new vaccines entering clinical trials, promising efficacies of the vaccines, and vaccines will enter the market soon) on social media


Response score, mean (SD)d 2.9 (0.9)


Almost none, n (%) 107 (10.2)


Seldom, n (%) 216 (20.5)


Sometimes, n (%) 420 (39.9)


Always, n (%) 309 (29.4)

Frequency of exposure to negative information related to COVID-19 vaccination (eg, concerns about efficacies and supplies, side effects of the vaccines, and receiving vaccines will cause COVID-19) on social media


Response score, mean (SD)d 2.3 (0.9)


Almost none, n (%) 244 (23.2)


Seldom, n (%) 366 (34.8)


Sometimes, n (%) 327 (31.1)


Always, n (%) 115 (10.9)

Frequency of exposure to testimonials given by participants of the COVID-19 vaccine clinical trials on social media


Response score, mean (SD)d 1.9 (1.0)


Almost none, n (%) 503 (47.8)


Seldom, n (%) 266 (25.3)


Sometimes, n (%) 185 (17.6)


Always, n (%) 98 (9.3)

Frequency of exposure to negative information about other vaccine incidents in China (eg, selling problematic vaccines and severe side effects) on social media


Response score, mean (SD)d 2.0 (1.0)


Almost none, n (%) 433 (41.2)


Seldom, n (%) 321 (30.5)


Sometimes, n (%) 207 (19.7)


Always, n (%) 91 (8.7)

aResponse categories for the 3-item Positive Attitude Scale were as follows: 1 (disagree), 2 (neutral), and 3 (agree). Cronbach α=.71; one factor was identified by exploratory factor analysis, explaining 64.0% of the total variance.

bResponse categories for the 4-item Negative Attitude Scale were as follows: 1 (disagree), 2 (neutral), and 3 (agree). Cronbach α=.64; one factor was identified by exploratory factor analysis, explaining 56.6% of the total variance.

cResponse categories were as follows: 1 (disagree), 2 (neutral), and 3 (agree).

dResponse categories were as follows: 1 (almost none), 2 (seldom), 3 (sometimes), and 4 (always).